Cipla Medpro

Cipla Medpro, South Africa's third-largest pharmaceutical company in the private sector, will also pay certain milestone payment for the stake acquisition over a period of three years, subject to meeting agreed profit targets.

Cipla shares up 2%, to launch biotech facility in South Africa

"...proposed biotech subsidiary in South Africa will invest just over R 1.3 billion into the country's first state-of-the-art biotech manufacturing facility, for the production of biosimilars," says the pharma company in its filing.

Cipla gains 2%, arm bags order from South Africa Govt

"Cipla Medpro, the third largest pharmaceutical company in South Africa, received R2 billion share of the South African Government‘s 2015-17 National ARV tender," said the company in its filing to exchange.

Cipla up 3% on collaboration with Teva for South Africa

The collaboration is a sales and distribution arrangement whereby Cipla Medpro will exclusively market Teva's broad pharmaceutical product portfolio in South Africa, says the company in its filing.

FY15 capex Rs 400 cr, aiming for 20% EBITDA growth: Cipla

Rajesh Garg, global chief financial officer, Cipla, told CNBC-TV18 that operating profits were impacted in the absence of anti-depressant Escitalopram sales in the US, and higher sales of anti-retroviral (ARV) drugs, where profit margins are low.

H1 inline; Cipla Medpro fully integrated: Cipla MD

Cipla MD & Global CEO Subhanu Saxena says he had signaled that the first 12-18 months in its roadmap was investing in the business for the future - particularly on people and also the pipeline to get in a position where it'll have sustainable platform for growth for the decade and beyond.

Cipla targets $5-billion revenue by 2020

Leading pharma player Cipla said it has targeted a revenue of USD 5 billion by 2020, of which USD 1 billion will come from the US market.

Cipla completes buyout of Cipla Medpro for Rs 2,707 cr

Drug major Cipla completed the buyout process of Cipla Medpro for Rs 2,707 crore. With this move, it completed 100 percent acquisition of the issued shares of the South African company.

Expect completion of Medpro takeover by mid-July: Cipla

The company had received approval from the Takeover Regulation Panel of South Africa on June 27, 2013 and that all conditions precedent to the scheme have now been fulfilled or waived, and accordingly, on June 27, 2013, the scheme has become unconditional, Cipla said in a filing to BSE.

Cipla gets nod from SA authorities to acquire Cipla Medpro

Cipla has received approval from the authorities of South African and Botswana for the USD 512 million takeover offer to acquire Cipla Medpro.

Cipla eyes strong intl growth; emerging mkts in focus

Cipla aims to focus more on international business and will strengthen its presense in US, Europe. The company is also closely eyeing emerging markets

Medpro buy to boost Africa biz sales by 2-3%: Cipla

Cipla's acquisition of South Africa's Cipla Medpro will boost Africa business revenue by 2-3 percent, Subhanu Saxena, CEO said on Thursday.

Cipla Medpro shareholders back buyout by India's Cipla

Shares in Cipla Medpro rose 1.9 percent to 9.65 rand by 0948 GMT, below the 10 rand per share offer.

Shareholders to decide Cipla Medpro takeover on Wednesday

CNBC-TV18‘s Archana Shukla reports that shareholders will decide Cipla India‘s USD 510-million dollar offer to take over Cipla Medpro on Wednesday.

Cipla Medpro wants Indian co to hike offer: Report

Sweet Consortium, which holds 18 per cent stake in Cipla Medpro, wants India's Cipla Ltd to sweeten its offer price from the proposed R10 per share for acquiring South Africa's third-largest generic drugmaker, according to a media report.

Cipla offers to buy South Africa's Cipla Medpro for $512m

Drugmaker Cipla said it has offered to buy all shares in South Africa's third largest drugmaker Cipla Medpro for a total consideration of about $512 million.

S.African Cipla Medpro says talks with Cipla ongoing

The acting chief executive officer of South Africa's Cipla Medpro said on Monday the generic drug firm has not received any communication from Cipla Ltd that an acquisition deal has been put on hold.

Cipla gains on partner's contract win

Shares in drugmaker Cipla rise 1.4 percent after Cipla Medpro won a share in South Africa's USD 667 million contract, as it supplies the bulk of Cipla Medpro's drugs.

Medpro buy to boost Cipla's growth in Africa, say analysts

Cipla's plans to buy beleaguered South African firm Cipla Medpro will help it boost its prospects in Africa, a key export market for the Mumbai-headquartered company, and will be accretive to earnings, analysts say.

Cipla eyes South Africa with plans for Cipla Medpro stake

S Radhakrishnan, ED, Cipla explains to CNBC-TV18 that the company is in discussions to acquire a 51 percent stake in Cipla Medpro, South Africa for a consideration of USD 220 million. The acquisition also offers a stake in Cipla Medpro business in South Africa.

Cipla to buy control of S. Africa's Cipla Medpro

Indian drugs maker Cipla Limited has offered to buy a about a 51 percent stake in South Africa's Cipla Medpro , to strengthen its position in the fast-growing African drugs market.